Financhill
Buy
59

AME Quote, Financials, Valuation and Earnings

Last price:
$170.11
Seasonality move :
2.13%
Day range:
$169.26 - $170.74
52-week range:
$145.02 - $198.33
Dividend yield:
0.68%
P/E ratio:
27.83x
P/S ratio:
5.69x
P/B ratio:
3.94x
Volume:
1.2M
Avg. volume:
1.6M
1-year change:
4.12%
Market cap:
$39.3B
Revenue:
$6.9B
EPS (TTM):
$6.11

AME Analysts' Consensus Rating

The 16 analysts providing 12-month price projections for AMETEK shares anticipate an average target of $190.80, ranging from a low estimate of $158.00 to a high estimate of $225.00. This average target implies a growth of 12.19% compared to the current stock price of $170.07.

Consensus Price Target

$190.80

Highest Price Target

$225.00

Lowest Price Target

$158.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 9 10 10

Hold 5 5 5

Sell 1 1 1
Consensus Buy Buy Buy

AME Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Adobe Stock a Bargain With AI Tools Driving Growth?
Is Adobe Stock a Bargain With AI Tools Driving Growth?

The share price of American computer software company Adobe (NASDAQ:ADBE)…

Is Palantir Stock a Millionaire Maker?
Is Palantir Stock a Millionaire Maker?

Palantir (NASDAQ:PLTR) has shot upward over the last year and…

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
4
CABO alert for May 3

Cable One [CABO] is down 41.98% over the past day.

Buy
55
PDEX alert for May 3

Pro-Dex [PDEX] is down 32.02% over the past day.

Buy
60
RGC alert for May 3

Regencell Bioscience Holdings [RGC] is down 22.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock